Hyperprogression After Immunotherapy for Primary Small Cell Neuroendocrine Carcinoma of the Ureter: A Case Report
BackgroundPrimary small cell neuroendocrine carcinoma (SCNEC) in the ureter is extremely rare and has been sporadically reported in case reports. Its incidence, diagnosis, treatment, and outcomes have not yet been thoroughly understood. Here we present a patient with advanced SCNEC in the ureter who...
Main Authors: | Defeng Qing, Luxing Peng, Feng Cen, Xinjun Huang, Qiang Wei, Heming Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.696422/full |
Similar Items
-
Cardiac infarction caused by PD-1 inhibitor during small cell neuroendocrine carcinoma of the ureter treatment: A case report
by: Xiaoying Li, et al.
Published: (2023-03-01) -
Clinical characteristics from a case of primary neuroendocrine carcinoma in the renal pelvis
by: Lin Hou, et al.
Published: (2023-12-01) -
Small Cell Neuroendocrine Cervical Carcinoma: A Case Report
by: Malihe Hasanzadeh, et al.
Published: (2021-02-01) -
Retrocaval ureter with ureteral calculus: Case report
by: Maher Al-Hajjaj, et al.
Published: (2020-11-01) -
Case Report: First Case of Consolidation Immunotherapy After Definitive Chemoradiotherapy in Mediastinal Lymph Node Metastatic Sarcomatoid Carcinoma
by: Yu Wang, et al.
Published: (2022-01-01)